Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolateScan in metastatic renal cell carcinoma
NCT01689766Phase 2Completed
- Sponsor
- Endocyte
- Start
- Nov 2003
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etarfolatide in metastatic renal cell carcinoma (mRCC), sponsored by Endocyte. Started Nov 2003; status: completed.
02
Drugs
etarfolatide
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01689766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689766.